Publications

22 Jun 2009
Research & Ideas

“Too Big To Fail”: Reining In Large Financial Firms

Here's a really scary thought. Now that the federal government has poured hundreds of billions of dollars into saving financial institutions deemed "too big to fail," hasn't it implicitly guaranteed similar largesse for all such... View Details

Keywords: by Roger Thompson; Banking; Financial Services

August 2008 (Revised September 2008)
Case

The Flaxil Label (A)

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details

Keywords: Governing Rules, Regulations, and Reforms; Health Disorders; Product Launch; Negotiation Process; Business and Government Relations; Safety; Pharmaceutical Industry

January 2023
Case

Natura: Weathering the Pandemic at Brazil's Cosmetic Giant

By: Brian Trelstad, Pedro Levindo and Carla Larangeira

Brazil's Natura, a multi-brand cosmetics group, has taken several measures to safeguard the livelihoods of its thousands of employees and millions of sales representatives during the COVID-19 health and economic crisis. The company has also made strides in its efforts... View Details

22 Jun 2017
News

ShotSpotter: A Gunfire Detection Business Looks for a New Market

March 1999 (Revised June 2005)
Case

Saevig Corporation

By: Henry B. Reiling and Mark Pollard

The taxpayer purchased land and later transferred it to a family controlled corporation in return for an earn out. When funds were eventually received, the IRS treated them as dividends, whereas the individual and corporate taxpayers contended they were sums paid on... View Details

Keywords: Investment Return; Debt Securities; Taxation; Outcome or Result; Financial Reporting; Family Business; Assets; Business and Stakeholder Relations

March 2018
Supplement

China Vanke: Battle for Control (D)

By: Lynn S. Paine, Charles C.Y. Wang, Dawn H. Lau and Anthony K. Woo

In the battle for control over China Vanke, the Chinese securities regulator steps in to censure Vanke and Baoneng for acting against the interests of the market and minority shareholders. The Chinese insurance regulator also finds Baoneng to be in violation of... View Details

Keywords: Corporate Governance; Governing Rules, Regulations, and Reforms; Governing and Advisory Boards; Business and Shareholder Relations; Conflict and Resolution; Real Estate Industry; China

Rakesh Khurana is the Marvin Bower Professor of Leadership Development at the Harvard Business School. He is also Professor of Sociology at Harvard University, co-Master of Cabot House at Harvard College, and the Danoff Dean of Harvard College.

Professor... View Details

Keywords: executive search

August 2008 (Revised September 2008)
Case

The Flaxil Label (B)

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details

Keywords: Governance; Risk and Uncertainty; Value Creation; Negotiation; Attitudes; Health Care and Treatment; Government Administration; Pharmaceutical Industry; United States

Web

Faculty & Advisors - MBA

Kennedy School of Government Mark Fishman, M.D. MS/MBA Program Faculty Co-Chair for MS Professor of Stem Cell and Regenerative Biology at Harvard University, Chief of Pathways Consult Service at Massachusetts General Hospital Douglas... View Details

10 Mar 2015
First Look

First Look: March 10

introduces methods for increasing the efficiency of retail store liquidation, which we define as the time-constrained divestment of retail outlets through an in-store sale of inventory. The retail industry depends extensively on... View Details

Keywords: Carmen Nobel

22 May 2007
First Look

First Look: May 22, 2007

had lower average returns during our sample period, but the difference in average returns is smaller than would be implied by the global CAPM given the historical equity premium. Download the paper: http://www.hbs.edu/research/pdf/07-084.pdf The Excess Burden of View Details

Keywords: Martha Lagace

March 2008
Case

Novartis AG: Science-Based Business

By: H. Kent Bowen and Courtney Purrington

Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in 2007. Pharmaceuticals account for slightly over $24B of that total. In 2007,... View Details

Keywords: Innovation and Invention; Resource Allocation; Product Development; Partners and Partnerships; Research and Development; Science-Based Business; Pharmaceutical Industry

2009
Working Paper

India Transformed: Insights from the Firm Level 1988-2005

By: Laura Alfaro and Anusha Chari

Using firm-level data this paper analyzes, the transformation of India's economic structure following the implementation of economic reforms. The focus of the study is on publicly-listed and unlisted firms from across a wide spectrum of manufacturing and services... View Details

Keywords: Transformation; Economic Sectors; Economy; Governing Rules, Regulations, and Reforms; Growth and Development Strategy; India

Read Now

Web

Programs & Events - Alumni

and employee satisfaction. Nov 20 20–22 NOV 2024 Executive Education HBS Campus Audit Committees in a New Era of Governance Meet evolving regulatory requirements while ensuring that financial reporting, compliance, and risk management... View Details

February 2008
Article

Attracting Skeptical Buyers: Negotiating for Intellectual Property Rights

By: James J. Anton and Dennis A. Yao

Expropriable disclosures of knowledge to prospective buyers may be necessary to facilitate the sale of intellectual property (IP). In principle, confidentiality agreements can protect disclosures by granting the seller rights to sue for unauthorized use. In practice,... View Details

Keywords: Corporate Disclosure; Intellectual Property; Knowledge Sharing; Lawsuits and Litigation; Rights; Agreements and Arrangements; Competition

Read Now

September 2009 (Revised January 2012)
Case

Suntech Power

By: Richard H.K. Vietor

Suntech, a Chinese manufacturer of photovoltaic cells and solar panels, is the third largest solar company in the world. About 90 percent of its sales have been in Europe—especially Germany and Spain. But with its new "pluto" technology, and with new governmental... View Details

Keywords: Solar Power; Renewable Energy; Globalized Markets and Industries; Competition; Market Entry and Exit; Business and Government Relations; Expansion; Strategy; Energy Industry; Green Technology Industry; China